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Abstract
The design and implementation of synthetic molecular communication systems (MCSs) at nano-
and microscale are very challenging. This is particularly true for synthetic MCSs employing biological
components as transmitters and receivers or as interfaces with natural biological MCSs. Nevertheless,
since such biological components have been optimized by nature over billions of years, using them
in synthetic MCSs is highly promising. This paper provides a survey of biological components that
can potentially serve as the main building blocks, i.e., transmitter, receiver, and signaling particles, for
the design and implementation of synthetic MCSs. Nature uses a large variety of signaling particles of
different sizes and with vastly different properties for communication among biological entities. Here, we
focus on three important classes of signaling particles: cations (specifically protons and calcium ions),
neurotransmitters (specifically acetylcholine, dopamine, and serotonin), and phosphopeptides. These
three classes have unique and distinct features such as their large diffusion coefficients, their specificity,
and/or their uniqueness of signaling that make them suitable candidates for signaling particles in synthetic
MCSs. For each of these candidate signaling particles, we present several specific transmitter and
receiver structures mainly built upon proteins that are capable of performing the distinct physiological
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2functionalities required from the transmitters and receivers of MCSs. One of the main advantages of
employing proteins for signal emission and detection is that they can be modified with tools from
synthetic biology and be tailored to a wide range of application needs. We discuss the properties and
limitations of the resulting synthetic MCSs in detail. Furthermore, we outline the possible challenges
arising in the implementation of the proposed transmitter and receiver architectures and options for
intersymbol interference mitigation for the considered signaling particles.
I. INTRODUCTION
The development of nanomachines for medical applications such as real-time health monitoring
and targeted drug delivery is a focus area of current nanotechnology research [1]–[3]. In order
to realize the full potential of such applications, it is necessary that the nanomachines be able
to efficiently communicate with each other [4]–[6]. For instance, a group of nanomachines may
detect a metabolic condition and communicate this observation to another nanomachine which
is then responsible for triggering the release of a drug into the body. Since conventional commu-
nication techniques are not well suited for communication at nano- and microscale, especially in
liquid media, molecular communication (MC), where molecules are used as information carriers,
has been proposed as a promising bio-inspired mechanism for enabling communication among
nanomachines [4], [5].
The general structure of a (synthetic) MC system (MCS) is depicted in Fig. 1. In response to
a certain input signal, which may be artificial (e.g. a light impulse, an electrical stimulation) or
biological (e.g. a nerve signal), the transmitter releases a pattern of signaling particles1, which
represents the information to be conveyed. The signaling particles propagate through the channel,
e.g. via free diffusion [7] where the propagation may further be accelerated by an external flow
[8]. The receiver observes the signaling particles and potentially takes action in response to the
received data. Thereby, the data may either be read out using an artificial mechanism (e.g. via
a light emission or an electrical current) or trigger a biological process (e.g. a nerve signal).
A. Motivation and Scope
Although synthetic MC has received considerable interest from the research community over
the past decade, the research area is still in its infancy. Thereby, the design, analysis, and imple-
1Throughout the paper we use the terms molecules and particles interchangeably, although the latter term is broader as not
all particles are molecules.
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Fig. 1. General block diagram of a molecular communication system. The color code used to represent transmitter, channel,
and receiver will be applied throughout the paper.
mentation of synthetic MCSs require inherently a multidisciplinary approach with contributions
from different engineering disciplines, including electrical, biological, and chemical engineering,
and different branches of science, including biology, chemistry, physics, and medicine. Partic-
ularly, the field of synthetic biology is expected to play a crucial role in the fabrication and
implementation of the main components of future synthetic MCSs, i.e., the transmitter, receiver,
and signaling particles.
So far, the main focus of the MC literature has been on the theoretical analysis and design
of synthetic MCSs, see e.g. [9]–[16]. In addition, as a proof of concept, MCSs have been
demonstrated at macroscale [17]–[21] and at microscale [22]–[27]. The latter systems employ
biological components as transmitter and/or receiver but were either demonstrated only for single
pulse transmission or offer very low data rates on the order of one symbol per hour. However,
for nano- and microscale MC to become practical, continuous transmission at much higher
data rates is needed. Both the design and the implementation of such systems requires a sound
understanding of the biological building blocks that can be used to construct them.
Several survey papers focusing on different aspects of MC have been published over the past
few years [4], [6], [28]–[30]. In particular, the authors of [4], [6] provide a general overview of the
field of MC, its future applications, and related challenges. In [28], a potential layer architecture
for MCSs is proposed. A general survey on synthetic MCSs, including aspects such as particle
transport, communication engineering aspects, testbeds, and applications, is presented in [29]. In
a recent survey, the authors of [30] discuss the potential use of synthetic MCSs for drug delivery
applications. Although [4], [29] also consider bio-nanomachines as components of MCSs, the
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4survey of the related literature is very brief. A comprehensive survey of potential biological
building blocks of MCSs is not available in the literature. On the other hand, there is a vast body
of literature in synthetic biology on biological systems that can potentially be used as components
of MCSs. However, for researchers not well versed in synthetic biology, it can be challenging to
find the relevant literature and to relate it to MCS design. Therefore, in this paper, we provide a
comprehensive survey of biological building blocks that can potentially be engineered to serve
as components of synthetic MCSs. Since, unlike what is often assumed in the MC literature,
biological systems are very specific, the signaling particles, transmitters, and receivers have to be
carefully matched to each other. In particular, the design of the transmitter and receiver in MCSs
crucially depends on the adopted signaling particles. Hence, in this survey, we adopt a signaling
particle centric approach and first present several candidate signaling particles for synthetic MCSs.
Then, for each of the considered signaling particles, we provide several candidate transmitter and
receiver structures. We believe that this survey is useful to both theoreticians and experimentalists.
For researchers working on the theoretical aspects of MCS design, taking into account the
specific properties of the proposed biological building blocks, which are reviewed here and
described in detail in the provided references from the synthetic biology literature, will allow
them to propose more realistic models and designs for MCSs. For researchers interested in
developing MC testbeds and experiments, the survey outlines the advantages and disadvantages
of potential design choices and the provided references contain the detailed information needed
for implementation. In the following subsections, we first explain some basic biological concepts
and components. Then, we provide a brief overview of the considered signaling particles and
matching biological components, which can be used to construct transmitters and receivers.
B. Some Important Basic Biological Concepts and Components
In the following, to assist readers that do not have a background in biology, we explain some
essential basic biological concepts and components used throughout this article. A summary of
additional biological concepts and terminology appearing in the text is provided in Appendix A.
• Vesicles: A vesicle is a small, round or ovalshaped container whose wall consists of a lipid
bilayer membrane which encloses a liquid substance [31]. Being much smaller than a cell,
natural vesicles are formed by deformation and subsequent budding from the cell membrane
or the membrane of cellular organelles such as the Golgi apparatus or the endoplasmatic
reticulum. They are used for transport purposes, e.g. in the context of secretion, for the
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5storage of certain biomolecules, and as compartments with particular reaction conditions.
Different proteins may be embedded in their lipid membrane which may facilitate for
instance transmembrane transport. Moreover, vesicles with transmembrane proteins can
be created artificially using tools of synthetic biology. Such artificial vesicles are called
liposomes.
• Ion channels: An ion channel is a special type of transmembrane protein with a pore
that becomes permeable for specific types of ions under certain circumstances [32]. Ion
channels only allow passive transport which means that they merely facilitate diffusion along
an already existing concentration gradient. Ion channels may be subdivided into different
groups based on the conditions that lead to channel opening (“gating”). For instance, there
are voltage-gated (a certain transmembrane potential is required), ligand-gated (a certain
molecule has to bind from the outside), and mechanosensitive (stretching of/pressure on the
membrane is required) ion channels [32].
• Carriers: Another kind of protein involved in the movement of ions or small molecules
across membranes are carriers [33]. The transported particles are also referred to as substrate
in this context. So called uniporters transport only one specific type of substrate. Upon
stimulation, they undergo a conformational change whereby the particle is carried through
the membrane to be released at the other side. Like ion channels, this is a form of passive
transport that only works in the direction of a concentration or charge gradient [33]. However,
there are carriers which do not transport one type of substrate alone, but two or more
different types of substrates (e.g. particles A and B) simultaneously, either both in the same
direction (symporter) or in opposite directions (antiporter). This principle, which is called
secondary active transport, allows to transport substrate A against its concentration gradient
if there is a sufficiently high concentration or charge gradient for substrate B that can be
used as a source of energy for the transport process. Often, the concentration gradient for
substrate B is actively maintained by use of an ion pump [33].
• Ion pumps: Similar to ion channels and carriers, ion pumps are transmembrane proteins
which can transport ions across a membrane. In contrast to ion channels, ion pumps use
an external source of energy such as light or adenosine triphosphate (ATP) to facilitate an
active transport which also works against the concentration gradient of the respective ion
[34].
• Voltage-clamp method: The voltage-clamp technique is a method where a microelectrode
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6is placed inside a vesicle or a cell to manipulate or measure the current across the vesicle
membrane at a certain voltage [35]. Thereby, changes in membrane potential can be induced,
e.g. in order to open a voltage-gated ion channel. Moreover, the two-electrode voltage clamp
technique can be used to measure the transmembrane current that arises when ion channels
are opened. The two-electrode voltage clamp technique allows adjustment of transmembrane
potential and recording of currents through separate electrodes [35], and is mostly used for
measurements on oocytes or very large vesicles/cells (> 1-2 mm in diameter) [36].
• Reversibility: In this article, we refer to transmitters as “reversible” if the signaling particles
are recycled after their release so that they can be used repeatedly. For example, a simple
vesicle-based transmitter may eventually get exhausted over time having released all signal
particles that were stored inside at the beginning. In contrast, a “reversible” transmitter is
able to regenerate its content, e.g. by pumping the signal particles back inside. In addition,
reversibility will require that the vesicle exhibits a high stability and remains intact during
multiple regeneration cycles of the transmitter.
C. Signaling Particles
Nature uses a vast number of different molecules for information exchange between different
entities. For concreteness, in this survey, we focus on three important types of signaling par-
ticles, namely cations, neurotransmitters (NTs), and phosphopeptides as a representative class
of modified proteins, see Fig. 2. These classes of signaling particles are attractive for use in
synthetic MCSs as they allow the design of simple transmitter and receiver structures employing
only a small number of protein components. Furthermore, as will be explained in the following,
the considered classes of signaling particles differ substantially in their behavior and properties,
such that they collectively can span a wide range of different applications.
Cations: Cations2 are small positively-charged ions that have the advantage of fast diffusion
[37], [38]. In addition, protons, as a specific ion, can jump from one water molecule to the
next through the formation and concomitant cleavage of covalent bonds, the so-called Grotthuss
mechanism [39], [40], which makes them appear to move even faster than they would already
be by classic diffusion due to their small size. Since ions interact with a plethora of proteins in
organisms [41]–[43], there exists a large set of possible biological structures that can be used
2In a similar manner, anions (i.e., small negatively-charged ions) can be used for signaling in MCSs.
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7as components of transmitters and receivers. Although many types of cations and anions may
be appropriate for MCSs, the present article focuses on protons due to their unique speed of
diffusion, and on calcium ions, because they play an important role as messengers in cellular
signaling [44]. For instance, calcium ions are involved in the process of apoptosis (programmed
cell death of damaged cells) [45] as well as in the coupling between the electrical excitation and
the consecutive contraction of muscle fibers [46].
NTs: As an alternative class of particles for MCSs, we consider NTs. NTs are bigger than
cations and therefore diffuse more slowly. On the other hand, they are more specific and are there-
fore more likely to avoid unintended signal interference from and to different natural processes
e.g. in the human body. The class of NTs comprises several distinct molecules (e.g. acetylcholine,
dopamine, and serotonin) that all function in a similar fashion in signal transduction. This has the
general advantage that similar building blocks can be used for the construction of transmitters
and receivers for different NTs. In nature, NTs are used to trigger or suppress neuronal firing
(the so-called action potentials) between neurons or from a neuron to a muscle fiber [47]. Thus,
NTs are particularly interesting because they could be used to directly interact with neurons [6],
e.g. in the context of nerve lesions which need to be bridged, the control of a prosthesis, and
the treatment of neurological diseases. One possible application would be targeted drug delivery.
For example, Parkinson’s disease which is caused by a selective loss of dopamine producing
neurons in a specific region of the brain, the so-called substantia nigra, is nowadays treated
by a systemic oral administration of levodopa, a precursor of dopamine synthesis [48]. In this
context, a direct delivery of dopamine via MC to the region where it is required would greatly
enhance the treatment effectiveness of Parkinson’s disease.
Modified proteins: The final class of signaling particles discussed in this article are proteins
that become signaling particles by post-translational modification (PTM). PTM describes a
covalent enzymatic modification of proteins that occurs after protein biosynthesis. There are
different types of PTMs (e.g. phosphorylation, methylation, acetylation, and ubiquitination),
which differ in their functional groups, their size, and the way they are linked to the protein
[49]. Protein phosphorylation, one of the most frequent types of PTM, is an important cellular
regulatory mechanism as many proteins (e.g. enzymes, receptors) are activated/deactivated by
phosphorylation and dephosphorylation events. More than two-thirds of the 21,000 proteins
encoded by the human genome were shown to be phosphorylated [50] indicating that phospho-
rylation plays a role in almost every physiological process. Abnormal protein phosphorylation
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8may lead to severe diseases including Alzheimer’s disease, Parkinson’s disease, and cancer. From
a communication-theoretic perspective, the protein moiety is always present in the channel but
it is only activated for signaling if it carries a phosphate group (orange phosphor with red
oxygen atoms in Fig. 2) that is transferred by a kinase [51], a special type of enzyme. We
consider phosphorylations because of their versatility due to the large number of different
signaling particles that can be generated by variation of the protein sequence. In addition,
phosphorylated proteins may be miniaturized to generate smaller signaling particles (henceforth
termed ‘phosphopeptides’) that have the advantage of faster diffusion due to their smaller size
compared to proteins.
Fig. 2 provides an overview of the properties of the different signaling particles that we survey
for their applicability in MCSs. From top to bottom, they are ordered according to their molecular
weights (MWs). As mentioned before, one common property of all three considered classes of
signaling particles is that their respective transmitters and receivers require only a few biological
components which makes them attractive for application in synthetic MCSs. In addition, they
are intrinsically rather homogeneous groups of signaling particles, which facilitates the design
of transmitter and receiver structures as well as communication protocols that can be applied to
multiple members of these classes.
Remark 1: We refrained from considering hormones as signaling particles in this survey,
because they are very divergent as far as their size (molecular weights from about 150 g/mol up
to insulin which is a protein with 51 amino acids and a molecular weight of 5800 g/mol), the
involved receptors (transmembrane, intracellular, and nuclear), and also the effect that they have
on their target cell are concerned [54]. Therefore, it is not possible to develop a general MCS
architecture valid for the entire group of hormones. We also do not consider complex biological
communication systems such as chemotaxis or bacterial quorum sensing, which require the
involved and difficult implementation of signaling cascades [55], [56]. Quorum sensing, for
example, depends on the conditional activation of gene transcription [56] and would thus only
be possible if complete bacterial cells were used as transmitters/receivers. In this paper, we focus
on the design of simple transmitters and receivers consisting of only a few protein components.
Remark 2: In the MC literature, there are several works that have analyzed the performance
and the design of MCSs for the signaling particles introduced above. For example, the use
of calcium/proton ions as signaling particles in MCSs is considered in [57]–[64]. Furthermore,
several theoretical works investigate the design and analysis of neuronal MCSs employing NTs
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9Fig. 2. Overview of the considered signaling particles, their molecular weight (MW), diffusion coefficient (D), and chemical
structure. Carbon atoms are colored in black, hydrogen atoms in white, oxygen atoms in red, nitrogen atoms in blue, and
phosphor atoms in orange. Diffusion coefficients were taken from [37] (protons, acetylcholine), [38] (calcium ions), and [52]
(dopamine, serotonin). The structure images were created using UCSF Chimera [53].
as information particles, see e.g. [65]–[70]. However, these existing theoretical works either
considered abstract models for the transmitter and receiver or focused on transmitter and/or
receiver structures of natural MCSs. In this paper, unlike the existing works, we investigate
different transmitter and/or receiver structures for each of the considered signaling particles
with the design of synthetic MCSs in mind. Furthermore, the proposed transmitter and receiver
structures are not limited to those existing in nature.
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Fig. 3. Exemplary protein structures of potential MCSs building blocks. For transmembrane proteins, the position of the
membrane is highlighted by two planes. All structures are listed with a unique identifier (PDB code) referring to the protein
data bank (www.rcsb.org). (a) Voltage-gated channel: Cav1.1 (PDB code 5GJV [71]). (b) Light-driven pump: Bacteriorhodopsin
(PDB code 1M0K [72]). (c) Fluorescent protein: Green fluorescent protein (GFP; PDB code 1GFL [73]). (d) pH-dependent
channel: Acid-sensing ion channel (ASIC; PDB code 4FZ0 [74]). (e) Ligand-gated ion channel: Serotonin receptor subtype
5-HT3A (PDB code 4PIR [75]). (f) Mechanosensitive ion channel: Transient receptor potential vanilloid 4 (TRPV4; PDB code
6C8F [76]). (g) NT symporter: Dopamine transporter (DAT; PDB code 4XP1 [77]). (h) G-protein coupled receptor (GPCR):
M3 muscarinic receptor (PDB code 4DAJ [78]). (i) NT degrading enzyme: Acetylcholinesterase (PDB code 4BDT [79]). (j)
Kinase: Mitogen-activated protein (MAP) kinase 1 (MEK1; PDB code 1S9J [80]). Structure images were created using UCSF
Chimera [53].
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D. Biological Components of Transmitter and Receiver
The signaling particles described above are compatible with several biomolecules that can be
used to construct transmitters and receivers for MCSs. An overview of some relevant classes of
such biomolecules is given in Fig. 3. One relevant protein family are channels that allow ions to
pass through a membrane via the channel pore in response to an external stimulus (e.g. voltage,
pH, ligands, or mechanical stress) (Figs. 3a, d, e, f). In contrast to such ion channels, which only
allow diffusion of ions along a concentration gradient, pumps (Fig. 3b) and symporters (Fig. 3g)
can move ions against a concentration gradient at the expense of energy consumption. G-protein
coupled receptors (Fig. 3h) detect ligands outside the cell and convert the corresponding signal
to intracellular responses. These biomolecules can be integrated into the membrane of cells or
artificial vesicles using the tools of synthetic biology [81]–[85]. In addition to these membrane-
bound components, there exist also soluble proteins with properties relevant for MCSs. For
instance, kinases (Fig. 3j) can convert peptides into signaling particles and enzymes (Fig. 3i)
allow the degradation of signaling particles. These biological structures will be discussed in more
detail as potential components of MCSs in the remainder of this paper.
E. Organization of the Paper
In the following, we outline how the remainder of the paper and the individual sections are
organized. In particular, in Sections II and III, we discuss transmitter and receiver mechanisms
for proton and calcium ions, respectively. In Section IV, the transmitter and receiver structures for
NT signaling particles are discussed. Section V introduces transmitters that use phosphorylation
as a mechanism for controlling the release of peptide particles as well as different receivers
that can detect phosphorylated peptides. Several extensions of the proposed transmitter/receiver
structures to more complex architectures, capable of performing more elaborate processing tasks,
are also discussed. In Sections II-V, the respective different synthetic transmitter and/or receiver
architectures are presented in order of increasing sophistication and required complexity for
integrating the necessary components into the transmitter and receiver. In addition to design
principles for synthetic transmitters and receivers, we also discuss natural mechanisms in the
body for the release and detection of the considered signaling particles. These mechanisms can
be interpreted as natural transmitters and receivers or natural sources of interference. We note that
there is no one-to-one mapping between the orders in which the transmitters and the receivers
are presented. In other words, depending on the specific application, the proposed transmitter
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and receiver structures can be flexibly combined. Furthermore, in Section VI, we present several
practical considerations for the implementation of MCSs including challenges in realizing the
proposed transmitter and receiver architectures, relevant biological mechanisms for inter-symbol
interference (ISI) mitigation, and bottlenecks for the achievable data rates.
II. PROTONS
Protons (represented by the symbol H+) are the first type of signaling particles we consider
for MCSs. The corresponding options for transmitter systems are depicted in Fig. 4, those for
receiver systems are presented in Fig. 5. They are described in detail in the following.
A. Transmitters
We consider six different transmitter structures (Fig. 4, T1-T6). While the first transmitter
(T1) is non-biological, transmitters T2-T5 consist of a vesicle containing an acidic solution and
employ different mechanisms for the controlled release and/or reuptake of protons. Finally, we
also briefly consider proton emitters (T6) which may naturally occur in the human body.
T1 (Pipette): The simplest transmitter for protons is a pipette by which an acidic solution is
released dropwise into the channel (Fig. 4, T1). This transmitter may be suitable for controlling
the release of protons at microscale.
T2 (Degenerating vesicle): As second and more complex transmitter system for protons, we
propose the usage of vesicles that contain an acidic solution (Fig. 4, T2). In the simplest case, the
release of the vesicle content could be triggered by adding a detergent destroying the membrane
or by means of electroporation [86] where the membrane permeability is increased due to an
externally applied electric field. Both approaches are very effective; however, they also destroy
the entire vesicle and thus release the entire content at once. In order to transport only partial
quantities of the signaling particles from the interior of the vesicle to the outside, different
transporter protein can be incorporated into the vesicle membrane as will be explained in the
following.
T3 (Ion channels): For the third transmitter model, we propose to use ion channels (e.g.
voltage-gated proton channels) for a controlled release of the signaling particles from the vesicle
(Fig. 4, T3). Voltage-gated ion channels are transmembrane proteins (Fig. 3a), which undergo
conformational rearrangements due to changes in the electrical membrane potential near the
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Fig. 4. Transmitters for protons as signaling particles. The suggested building blocks for different transmitter systems are
presented in order of increasing complexity including designed artificial systems and physiological emitters, which may naturally
occur in the human body.
channel. Such changes of membrane potential can be induced artificially, e.g. by the voltage-
clamp technique [35]. The channel opens through these conformational changes and ions can
leave the vesicle. Voltage-gated proton channels exhibit a high selectivity allowing only protons
to leave the vesicle [87], which makes them perfect candidates for outward transportation.
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T4 (Ion pumps): Alternatively, for the fourth transmitter model, we exploit light-driven or ATP-
driven pumps for the proton transmitter system (Fig. 4, T4). While voltage-gated ion channels
conduct cations or anions in a passive manner, ion pumps need an external source of energy and
function as active transporters, which allows them to build up a proton concentration gradient
[88]. As light-driven outward proton pump, we propose for instance bacteriorhodopsin [89]
(Fig. 3b), which can be embedded in the membrane of proton containing vesicles. In particular,
there are several known variants of bacteriorhodopsin which differ in the required wavelength for
activation [90]. Recently, an experimental testbed employing bacteriorhodopsin has been reported
in [57]. As an ATP-driven pump, V-ATPases or P-ATPases [91] could be used and activated by
addition of ATP in the vicinity of the vesicle.
T5 (Inward ion pumps): The last two proposed transmitter mechanisms (Fig. 4, T3 and T4)
enable the controlled release of signaling particle; however, they are lacking reversibility, i.e.,
the recycling of the signaling particles by the transmitter. By recycling the signaling particles,
the transmitter can harvest some of the previously released protons for future releases. Moreover,
when transmitter and receiver are placed close to each other, as e.g. in the synaptic cleft, recycling
the signaling particles aids in clearing the channel for future releases, and thereby, reducing ISI.
Reversibility can be achieved by adding a second biomolecule that transports the signaling
particle back into the vesicle after signal detection. As inward transporter, light-driven inward
proton pumps can be additionally integrated into the vesicle [88]. These inward pumps are able
to transport protons from the surrounding solution into the interior of the vesicle (Fig. 4, T5).
In case that light-driven outward proton pumps are used for signaling particle release (Fig. 4,
T4), it is important to choose outward and inward proton pumps that are activated by different
wavelengths in order to avoid the simultaneous operation of both proton pumps.
Remark 3: In Fig. 4, light-driven pumps are labelled by hν because the energy of the photon
used as a driving force may be calculated as E = hν, where h denotes the Planck constant and
ν is the frequency of the light [92]. In T5, the inward light driven pump is referred to as hν ′,
indicating to the fact that a different activation frequency/wavelength is needed compared to the
outward pump.
T6 (Natural transmitters): Besides these designed synthetic transmitter systems (T1-T5),
there are also some processes in the human body that may be interpreted as proton emission.
For example, some tissue has a higher proton concentration (lower pH value) than other tissue
(Fig. 4, T6). Lower pH values can be observed e.g. in inflamed tissue but also the extracellular
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pH of tumors can be heterogeneous and acidic [93], which may be used for detection of cancer
cells.
B. Receivers
Protons as signaling particles lead to an increase of the proton concentration at the receiver
or equivalently a reduction of the solution pH. We discuss five possible synthetic receiver
architectures (R1-R5) for protons and two natural processes in the human body (R6, R7) that
are triggered by changes in the proton concentration.
R1 and R2 (pH sensors): The simplest approaches to detect a change in the proton concentration
of a solution are pH-measuring instruments (Fig. 5, R1) and pH-sensitive dyes (pH indicators)
(Fig. 5, R2) as they are routinely used in chemical and biological laboratories. The changes of
dye colors can for example be detected by photometry in a second step.
R3 (Fluorescence proteins): In biological experiments, pH-sensitive fluorescence proteins are
also often used as pH indicators and they are good candidates for use in nanoscale MCSs. One
example for such a fluorescent protein is the green fluorescent protein (GFP) (Fig. 5, R3) with
its characteristic β-barrel structure and the fluorescent chromophore (fluorophore) in the center
(Fig. 3c). The fluorescence is dependent on the protonation of the fluorophore and in the last
years many different variants were developed, which possess an altered pH-sensitive excitation
spectrum. For some of these variants, a response time of less than 20 ms could be demonstrated
[94]. Besides GFP variants with disappearing fluorescence through decreasing pH values, also
GFP variants which emit light of different color at different pH values were reported [95]. For
example, for excitation at 388 nm, the GFP from the sea cactus Cavernularia obesa has a blue
fluorescence at pH 5 and below, whereas it shows a green fluorescence at pH 7 and above [96].
R4 (FRET): Another possibility for a receiver system is the usage of biomolecules, which
undergo large conformational changes upon a decrease in the surrounding pH value. One example
are peptides consisting of polyglutamate, which form α-helices in acidic solution while being
disordered at intermediate or high pH (Fig. 5, R4) [97]. This conformational rearrangement of the
structure can be visualized and made detectable with a coupled FRET (Fo¨rster resonance energy
transfer or fluorescence resonance energy transfer) experiment. The underlying mechanism is an
energy transfer between two light-sensitive molecules (chromophores). A donor chromophore,
which is excited by irradiation with light of a certain wavelength, transfers energy to an acceptor
chromophore. The shorter the distance between the two chromophores, the more energy can be
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Fig. 5. Receivers for protons as signaling particles. The suggested building blocks for different receiver systems are presented
in order of increasing complexity including designed artificial systems and physiological receivers, which naturally occur in the
human body.
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transferred from the donor to the acceptor chromophore. Hence, FRET is very sensitive to small
changes in distance between the chromophores. This effect can be read out by monitoring the ratio
of the respective light intensities emitted by the donor and the acceptor at different wavelengths.
Alternatively, the intensity of the donor can be compared in the presence and absence of the
acceptor [98].3 We propose the construction of a FRET-based receiver employing a fusion protein
with two FRET partners at the termini and a polyglutamate sequence in between as described
in [97]. Upon helix formation in acidic pH, the distance between the two ends decreases. In
biological experiments, a common donor-acceptor pair is the cyan fluorescent protein (CFP)
combined with the yellow fluorescent protein (YFP) [95], [104] which are both color variants
of GFP (Fig. 3c).
R5 (Proton-gated channels): As a further option for a pH-dependent receiver system, we
propose the usage of proton-gated channels, like acid-sensing ion channels (ASICs, Fig. 3d) [105],
[106] or proton-gated proton channels (e.g. the viral p7 protein) [107] embedded in a vesicle
(Fig. 5, R5). These ligand-gated ion channels are permeable for certain types of cations after
activation by high proton concentration at their extracellular side [105], [106]. The cations can
flow via the channel pore in the vesicle membrane into the interior of the vesicle and increase the
concentration of cations in the vesicle, which can be detected by measuring the transmembrane
current by methods such as the two-electrode voltage clamp method [36]. For reversibility, an
additional light-driven outward pump (e.g. KR2 of the marine bacterium Krokinobacter eikastus
[108] for sodium ions or bacteriorhodopsin for protons) can be embedded into the vesicle
membrane. With such light-driven pumps, it would be possible to pump the cations from the
interior of the vesicle back into the surrounding solution.
R6 (Proton-triggered protein dissociation): In nature, there are numerous examples where
a protein complex dissociates in response to decreasing pH values (Fig. 5, R6). One such
example is described for the periplasmic protein HdeA, which forms a well-folded homodimer
at neutral pH. Under acidic conditions, HdeA unfolds and exhibits an enhanced tendency to
dissociate into monomers [109], [110]. Another example is the human Hsp47 protein, which is
a collagen-specific molecular chaperone and indispensable for molecular maturation of collagen
[111]. Hsp47 transiently binds to procollagen in the endoplasmic reticulum (ER, neutral pH) and
3We note that the underlying FRET mechanism as an option for communication at nanoscale has been theoretically investigated
in [99]–[103].
January 9, 2019 DRAFT
18
dissociates from it in a pH-dependent manner once this complex is transported to a compartment
with lower pH (e.g. the cis-Golgi or the ER-Golgi intermediate compartment) [111]. These
examples demonstrate that various physiological processes may be triggered by modulating
proton concentrations.
R7 (Proton-modulated “acidic-metabolic” vasodilatation): In the body, decreasing pH val-
ues during hypoxia/ischaemia can also lead to a physiological mechanism known as “acidic-
metabolic” vasodilatation [112] (Fig. 5, R7), which improves blood flow and oxygen supply.
Vasodilator nitric oxide (NO) is generated through a non-enzymatic reduction of inorganic nitrite
(NO−2 ) to NO, a reaction that takes place predominantly during acidic/reducing conditions [112].
Thus, “acidic-metabolic” vasodilatation represents another physiological process that may be
modulated by proton-based synthetic MCSs.
III. CALCIUM IONS
Besides protons, other types of ions may be suitable for synthetic MCSs as well. In many cases,
there exist building blocks similar to those presented in Section II. Due to their particular role as
second messengers4 in the human body, we illustrate in this section how the concepts proposed for
protons may be transferred to calcium ions (represented by the symbol Ca2+). Table I summarizes
the proposed building blocks and underlines the high similarity of the underlying components
for both types of signaling particles.
A. Transmitters
The non-biological transmitter T1 (pipette) as well as the simple vesicle-based transmitter
T2 (degenerating vesicle), which does not contain specific membrane proteins, may be adapted
for calcium ions simply by replacing the acid with a solution containing a calcium salt such as
CaCl2. Compared to protons, there are some additional degenerating carriers triggered by light
or temperature which may be used as an alternative5.
4Intracellular chemical substance whose concentration changes upon a primary signal, e.g. a ligand binding to a transmembrane
receptor [113].
5One type of such carriers may be so-called light-sensitive caged compounds [123], [124], which are already commercially
available. Like in the vesicle, the calcium ions are shielded at the beginning and thus biologically inactive, which is due to a
bound photoswitchable molecule. Upon irradiation with light of a certain wavelength, the shielding agent gets cleaved and the
calcium ions are released from their cage [123], [124]. The same general concept, but with heat instead of light as a trigger
mechanism, could also be realized by the use of thermosensitive microcapsules as described in [125].
January 9, 2019
19
TABLE I
TRANSFERABILITY OF THE BUILDING BLOCKS SUGGESTED FOR PROTONS (FIGS. 4 AND 5) TO MCSS USING CALCIUM IONS
AS SIGNALING PARTICLE. COMPARISON OF POSSIBLE TRANSMITTERS AND RECEIVERS.
Component Protons (H+) Calcium ions (Ca2+)
T1 (Pipette) Pipette with acidic solution Pipette with solution containing calcium
salt (e.g. CaCl2)
T2 (Degenerating carriers) Vesicle with acidic solution Vesicle with calcium ions, alternatively
light-sensitive caged calcium or thermosen-
sitive microcapsules
T3 (Ion channels) Vesicle with acid and passive transport via
voltage-gated proton channel [87]
Vesicle with calcium ions and passive trans-
port via calcium channel, different gating
mechanisms:
• Voltage-gated (e.g. Cav1.1 [114])
• Ligand-gated (e.g. 5-HT-3A + serotonin
[115])
• Mechanosensitive (e.g. TRPV4 [116])
T4/T5 (Ion pumps) Vesicle with acid and active transport via
proton pump, different energy sources:
• Light-driven (e.g. bacteriorhodopsin [89])
• ATP-driven (e.g. V-ATPases, P-ATPases
[91])
Vesicle with calcium ions and active trans-
port via calcium pump, different energy
sources:
• Light-driven (e.g. engineered pump from
[117])
• ATP-driven (e.g. Ca2+-ATPase [118])
R1 (Measuring instrument) pH-meter Conductivity measuring instrument
R2 (Dye) pH-sensitive dye/pH indicator Calcium-sensitive fluorescent dye (e.g.
Fura-2, Indol-1, Fluo-3, Fluo-4, Calcium
Green-1 [119], [120])
R3 (Fluorescence proteins) GFP (different variants available) [94], [96] Fusion constructs of GFP variants and
calmodulin (e.g. GCaMP [121])
R4 (FRET) α-helix stabilization due to protonation, flu-
orescence proteins at the termini forming a
FRET pair [97]
Calcium indicators containing troponin C
and a FRET pair (e.g. TN-XL (CFP+YFP)
[122])
Biological transmitters T3-T5 can be constructed by replacing the described proton channels
and proton pumps in Fig. 4 by calcium-specific proteins with an analogous function. Some
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suggestions for how this could be realized in detail are given below.
T3 (Ion channels): As proposed for protons, the outward transport of calcium ions may be
accomplished with ion channels as well. There exist some voltage-gated channels for calcium
ions such as Cav1.1 [114] (Fig. 3a). Although a stimulation by electricity would be convenient
in testbeds and for applications outside the human body, the medical use of MCSs may require
a release of calcium ions by triggers which are less invasive and therefore more biocompatible.
Fortunately, for calcium ions, there are some additional gating mechanisms available compared
to protons.
One particular interesting example are ligand-gated channels. These ion channels become only
permeable if a ligand binds from the outside causing thereby a conformational change of the
protein. One possible candidate for calcium ion receptors is the 5-HT-3A receptor [115] (Fig. 3e)
which opens in response to serotonin. So, serotonin could be administered in order to release
calcium ions from the vesicle. Since serotonin is a NT (see Section IV) and thus a natural
signaling particle of the human body, it might even be possible to couple the calcium release
directly to the activation of a serotonergic6 neuron. This would allow to use the input from a
nerve fiber for activation of the transmitter. This general principle can also be applied to other
pairs of ligand-gated channels and their physiological ligand, of course. This allows for the direct
coupling of a biological process and the MCS.
Another interesting option are mechanosensitive calcium channels, which are opened in re-
sponse to mechanical stress [126]. One possible approach could be the insertion of the vesicles
between the fibers of the extracellular matrix at some location in the body. Upon mechanic shear
or pressure on the respective tissue, a calcium release would be triggered. This principle could be
useful in the context of targeted drug delivery, e.g. in order to facilitate the local administration of
an anesthetic. One example for such a mechanosensitive calcium channel involved in nociception,
i.e., the encoding and processing of pain stimuli in the human body, is the transient receptor
potential vanilloid 4 (TRPV4) [116] which is depicted in Fig. 3f.
T4/T5 (Ion pumps): Besides passive channels, similar to protons, calcium ions can actively be
transported using either a light-driven pump, that has been artificially created [117], or an ATP-
driven Ca2+-ATPase [118]. If two light-driven pumps are intended to be used in the same vesicle
to allow for transmitter regeneration (reversibility), the second pump would need to be engineered
6Neuron/synapse which produces serotonin or uses serotonin as a neurotransmitter.
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to work at a different wavelength as has already been reported for some bacteriorhodopsin
mutants [90].
B. Receivers
Regarding possible receivers for calcium ions, building blocks which are similar to R1-R4
presented for protons can be employed (see Table I for a comparison).
R1 (Conductivity measurement): In response to the release of calcium ions, the conductivity of
the medium surrounding the transmitter would increase. Analogous to the usage of a pH-meter
in case of protons, the easiest way to construct a receiver for calcium ions is thus an instrument,
which can measure the conductivity of the solution in the channel. While this approach might be
suitable for testbeds and applications outside the body, it is challenging for biological systems
because the high background concentration of other ions in the environment requires the detection
of rather small changes of the total ionic strength.
R2 (Fluorescent dye): Similar to a pH indicator, a calcium-sensitive fluorescent dye could be
used to detect changes in the calcium ion concentration. When such a dye is illuminated with
light of a certain wavelength, fluorescence occurs if calcium ions are present. Examples for such
dyes are Fura-2, Indol-1, Fluo-3, Fluo-4, and Calcium Green-1 [119], [120], which all have a
high specificity for calcium ions in common.
R3 (Fluorescence proteins): For the third receiver structure, we propose the use of calcium-
sensitive fluorescent proteins. They are generally fusion constructs of GFP (Fig. 3c) or one of
its variants, and the calcium-binding protein calmodulin. One example is GCaMP [121] which
shows only feeble activity if calcium ions are absent, but undergoes a conformational change
upon calcium binding leading to a pronounced fluorescence.
R4 (FRET): Alternatively, as described for protons, calcium ions may be detected via receivers
relying on the FRET mechanism [122], [127]. There exist calcium ion indicators which are
based on a FRET pair of two different fluorescent proteins, connected via the calcium-binding
protein troponin C. One example, TN-XL [122], consists of CFP and YFP. If no calcium ions
are present, the protein has an extended conformation where the two fluorescent subunits are
distant from each other. If CFP is activated by illumination with a certain wavelength, only cyan
fluorescence occurs. As soon as a calcium ion binds to troponin C, the conformation of the
fusion protein changes, such that the two fluorescent building blocks get into mutual vicinity.
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Upon illumination and activation of CFP, the energy is partly transferred to YFP via FRET so
that yellow fluorescence can be observed as well.
IV. NEUROTRANSMITTERS
Another important class of signaling particles well suited for the design of synthetic MCSs
are NTs such as acetylcholine, dopamine, and serotonin. In the human body, NTs are used to
transmit nerve signals (action potentials) at the chemical synapses between two neurons (e.g.
dopamine, serotonin) or from a neuron to a muscle fiber (acetylcholine) [47]. In this section,
we describe some general principles and building blocks for the design of synthetic transmitters
and receivers for NTs. The general design strategies for the transmitter systems are depicted in
Fig. 6, those for the receiver systems are presented in Fig. 7. These general design principles can
be applied to all three NTs discussed in this survey. Thus, the most suitable NT can be selected
depending on the requirements imposed by the desired application. It is important to note that
the design of a specific signaling pathway requires the choice of suitable protein components
depending on the type of NT used. Candidate components for acetylcholine, dopamine, and
serotonin are summarized in Table II.
A. Transmitters
In the following, we consider six different possible types of transmitters for NTs. The first two
transmitters (T1, T2) are non-biological and simple but are limited to microscale applications.
Transmitters T3-T5 are vesicle based and employ different biological mechanisms for NT release.
The final transmitter (T6) is the axon terminal of a nerve fiber.
T1 (Pipette): Analogous to cations (Fig. 4, Table I), the simplest and least sophisticated trans-
mitter is a pipette by which a solution containing the NTs can be released dropwise into the
channel (Fig. 6, T1).
T2 (Caged compounds): As described for calcium ions, another interesting concept, which is
based on shielding the NTs until they need to be released, are so called light-sensitive caged
compounds (Fig. 6, T2). In this approach, the NTs are enclosed and thus inactivated by a pho-
toswitchable molecule. Upon irradiation with light of a certain wavelength, the photoswitchable
molecule is either cleaved or changes its conformation and as a consequence, the NTs are released
from their cage. Caged compounds have been developed for acetylcholine, dopamine, serotonin,
and many other NTs [128]–[130]. Some of them are already commercially available. Recently,
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Fig. 6. Transmitters for NTs as signaling particles. The suggested building blocks for different transmitter systems are presented
in order of increasing complexity including designed artificial systems and physiological emitters, which naturally occur in the
human body.
caged serotonin has been suggested to be used for targeted drug delivery in the context of
neurodegenerative diseases [130]. Alternatively, the NTs could be shielded using thermosensitive
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Fig. 7. Receivers for NTs as signaling particles. The suggested building blocks for different receiver systems are presented in
order of increasing complexity including designed artificial systems and physiological receivers, which naturally occur in the
human body.
microcapsules [125] which release their content upon an increase of temperature.
T3 (Degenerating vesicles): Vesicles containing a solution of particular NTs may be used as
transmitter (Fig. 6, T3). As a simple option, the vesicle can be destroyed to release its content as
described previously. However, this has the disadvantage that only a one-time release is possible.
T4 (Symporters): If a vesicle-based approach is used as suggested in T3, a transmitter which
pumps the NTs in a more controlled manner from the inside of the vesicle into the channel
may be a better option than simply destroying the vesicle and releasing its entire content at
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once. To this end, special proteins for the outward transport of the NTs maybe inserted into
the vesicle membrane. One possible outward transporter are NT sodium symporters (Fig. 6, T4),
which are driven by a sodium concentration gradient [131]. The structure of sodium symporters
for the target NT dopamine, i.e., dopamine transporters, is shown in Fig. 3g. In particular, the
underlying mechanism of sodium symporters is as follows: When both a sodium ion and an
NT bind to the transporter simultaneously, they are carried across the vesicle membrane by a
conformational change of the transporter. This means that the NT will be pumped outwards as
soon as a sodium concentration gradient from the inside to the outside is established. Such a
sodium gradient may be realized by a light-driven sodium pump which transports sodium inside
when it is illuminated by light of a certain wavelength. Thus, the combination of an NT-sodium-
symporter and a light-driven sodium-pump can be used for a finely controllable release of NTs
from the vesicle.
T5 (Antiporters): An alternative strategy with the same level of complexity and controllability
as the previous transmitter structure (T4) is to use vesicles with NT antiporters instead of
symporters [132] (Fig. 6, T5). In contrast to sodium symporters, in this case, the driving force
for transportation of NTs across the vesicle is a proton gradient. In particular, if a proton binds
to the antiporter from the outside of the vesicle and an NT simultaneously from the inside, a
conformational change occurs by which the proton is transported inside and the NT is transported
outside. To avoid a constitutive NT release, the inside of the vesicle has to be more acidic than the
surrounding channel when the transmitter is inactive. Coupled with a light-driven proton pump
such as bacteriorhodopsin, one can then remove protons from the vesicle upon illumination with
a certain wavelength and thereby induce a proton gradient towards the inside which triggers a
controlled release of the NT.
T6 (Natural transmitters): Besides the vesicle-based transmitters (T3-T5), a main advantage
of NTs is the possibility to directly use a physiological transmitter, i.e., the axon terminal
(presynaptic part) of a nerve fiber in the human body (Fig. 6, T6). Upon excitation of a nerve fiber,
an electric signal (action potential) is generated, moves along the axon terminal, and triggers
the release of the NTs, which are stored in vesicles [132]. This natural biological transmitter
is inexhaustible because the vesicles are regenerated by the neuron. Possible applications of
such a direct interface to a neuron [6] are the bridging of nerve lesions, the release of drugs in
certain conditions (e.g. an analgesic combined with a neuron involved in pain reception), and
the movement of a prosthesis.
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B. Receivers
In this subsection, we discuss two synthetic receivers for NTs which employ NT receptors
embedded into the membrane of a vesicle. Such NT receptors exist in the human body, e.g. in
postsynaptic cells, and there are different types of NT receptors. Here, we consider ligand-gated
sodium channels such as the serotonin 5-HT3A receptor (R1, Fig. 3e) and G-protein coupled
receptors (R2, Fig. 3h). In addition, we also consider one natural receiver for NT which can
serve as an interface for the control of biological systems (R3).
R1 (Ligand-gated ion channels): For ligand-gated sodium channels, upon binding of the target
NT, a pore in the receptor is opened which allows sodium ions to pass through the membrane
[133]. Based on the concentration gradient, sodium ions move from the outside to the inside
of the cell, which leads to the formation of a transmembrane current that can be measured by
methods such as the two-electrode voltage clamp method (Fig. 7, R1, upper panel) [36]. For
proper functionality of the vesicle, the concentration of sodium ions inside the vesicle has to
be lower than the concentration outside. To ensure that after detection the required sodium ion
gradient is restored to enable future receptions, reversibility has to be integrated in the vesicle.
This can be accomplished by further integrating light-driven sodium-pumps into the membrane
of the vesicle (Fig. 7, R1, lower panel) [134]. Then, the light-driven sodium pumps can operate
e.g. in the time interval between two consecutive transmissions to pump out the sodium ions so
that the receiver is replenished.
R2 (GPCRs): Besides ligand-gated ion channels, G-protein coupled receptors (GPCRs) are
another class of receptor for NTs [133]. The structure of one example GPCR, namely the
M3 muscarinic receptor, is shown in Fig. 3h. When an NT binds to a GPCR, this leads to
a conformational change of the receptor. This conformational change is conveyed to the inside
of the cell via an intracellular binding protein such as a G-protein or arrestin, where it may
activate or inhibit a variety of second messenger molecules and thereby have an impact on the
cell metabolism [135]. Such a GPCR could also be used as reception mechanism for an NT-based
MCS (Fig. 7, R2). However, this setup will most probably require an intact cell, which has such a
receptor in its membrane, because it would be extremely difficult to synthetically reconstruct the
corresponding complex signaling cascade in a vesicle. There are several commercially available
kits which use FRET experiments to detect the level of GPCR activation.
R3 (Natural receivers): NTs can be used to directly interact with biological systems. For
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example, if the NTs are released in proximity of a postsynaptic terminal or a muscle fiber, they
may stimulate a nerve or induce a muscle contraction (Fig. 7, R3). This stimulation occurs
by binding of an NT to a receptor, e.g. a ligand-gated ion channel, on the membrane of the
postsynaptic terminal. The resulting ion influx leads to a depolarization of the cell membrane
which propagates then as a new action potential along the cell. This principle can be exploited
in medical applications of MC [6] for bridging of nerve lesions or targeted intervention into a
deregulated neuronal circuitry, e.g. in the context of neurodegenerative diseases.
TABLE II
COMPARISON OF DIFFERENT NTS AS SIGNALING PARTICLES. EXEMPLARY OPTIONS FOR DIFFERENT COMPONENTS.
Component Acetylcholine Dopamine Serotonin
T3-T5 Vesicle yes yes yes
T4 Symporter
(sodium-driven)
— dopamine transporter
(DAT) [78]
serotonin transporter
(SERT) [136]
T5 Antiporter
(proton-driven)
vesicular acetylcholine
transporter (VAChT)
[137]
vesicular monoamine
transporter 2 (VMAT2)
[138]
vesicular monoamine
transporter 2 (VMAT2)
[138]
T6 Physiological
transmitter
axon terminal at
neuromuscular junction
[139]
axon terminal in the
central nervous system
(CNS); regulation of
executive functions,
motor control, motivation,
arousal, reinforcement,
and reward [140]
axon terminal in the
CNS; regulation of mood,
emotion, memory
processing, sleep,
cognition [140]
R1 Ligand-gated channel nicotinic acetylcholine
receptor (nAChR) [141]
— serotonin receptor
subtype 5-HT3 [142]
R2 G-protein coupled
receptor (GPCR)
muscarinic acetylcholine
receptors (mAChR1)
M1−5 [143]
dopamine receptors
DRD1-DRD5 [144]
serotonin receptor
subtypes 5-HT1,2,4−7
[145]
R3 Physiological receiver trigger contraction of
muscle fiber [139]
trigger nerve impulses in
the CNS [140]
trigger nerve impulses in
the CNS [140]
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V. PHOSPHOPEPTIDES
As outlined in Section I-C, protein modifications represent a widespread principle of signal
transduction in nature. Phosphorylation, where a phosphoryl group is added to a peptide, repre-
sents one of the most frequent modifications in cellular signaling, and will be considered in the
following in more detail. To exploit this principle for the design of MCSs, it appears advisable
to reduce the size of the respective phosphoproteins to the vicinity of the phosphorylation sites.
These smaller ‘phosphopeptides’ have the advantage of faster diffusion due to their smaller size
compared to intact proteins.
Phosphopeptides are complementary to the particles described in the previous sections as they
have very different properties. The most important difference is that peptides do not function
in isolation, but require attachment to a chemical functional group. This step is mediated by
a kinase, a specific type of enzyme. It is important to note that the peptide unit represents
more than a mere carrier molecule to transport the phosphoryl group from the transmitter to the
receiver but also plays an important role for the specificity of the signal transduction process.
The proteins discussed as receivers below generally do not only recognize the phosphoryl itself,
but also the physico-chemical properties of the peptide in its vicinity. This allows to design
various types of phosphopeptides with different signaling specificity.
A. Transmitter
In contrast to the systems described in Sections II-IV, in the case of peptide modifications,
the signaling particles do not need to be stored at the transmitter but can be generated upon
a stimulus (e.g. light or external ligand), see Fig. 8. The stimulation is provided by kinases
that transfer a phosphoryl group from the chemical energy carrier molecule ATP to a peptide,
thereby creating a phosphopeptide, the signaling particle. In this process, ATP is hydrolyzed to
adenosine diphosphate (ADP), which can be regenerated to ATP by other cellular processes.
For phosphorylation, several different peptides and corresponding kinases are available. The
human proteome contains at least 518 different protein kinases [146]. Most protein kinases
phosphorylate either the amino acids serine/threonine or tyrosine (specific types of amino acids).
However, there are also dual specific protein kinases (DUSPs) that can phosphorylate both
serine/threonine and tyrosine residues. Within these groups, kinases additionally differ in their
specificity, i.e., the amino acid sequence in the environment of the potential phosphorylation site
can determine whether an amino acid becomes phosphorylated by a certain kinase or not. Due
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Fig. 8. Phosphopeptides as signaling particles. General composition of the communication system, which uses switchable kinases
(activation by light, ligands, or pH change) as transmitters. The receiver consists of a phosphopeptide-binding domain, which
allows detection of the binding process via changes in tryptophan fluorescence or in the mass of the complex.
to the large variability of the peptide sequences with the corresponding kinases, a large number
of different signaling particles is available.
An important prerequisite for the use of signaling particles in MCSs is the controllability
of particle generation, i.e., in this case, the ability to switch the kinases on and off. Because
kinase activity has profound effects on cellular processes, protein kinases are generally highly
regulated, i.e., there are many mechanisms for switching them on and off. Kinases may be turned
on and off by posttranslational modification (phosphorylation, ubiquitination) [147], [148], pH
changes [149], and binding of regulatory proteins [150]. The switchability of protein kinases has
further been increased by engineering ligand-controlled allosteric switches [151], [152] and the
design of a photoresponsive small molecule that becomes an active inhibitor when exposed to
light [153]. Ligand-independent light-induced kinase activation has been engineered in receptor
tyrosine kinases [154], [155] as well as soluble kinases [156].
B. Receiver
For the detection of phosphorylated peptides, there exists a large set of protein domains in
nature that may be used as receivers in synthetic MCSs. The binding of the phosphopeptide to
such domains can for example be detected by a change in tryptophan fluorescence that occurs
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upon binding (Fig. 8). Alternatively, the change in mass upon peptide binding may be detected
via surface plasmon resonance [157].
Similar to the versatility on the transmitter side, there exist many different adapter domains that
can be used as specific receivers. Serine/threonine phosphorylated peptides can be recognized
by a large number of different domain types, including 14-3-3, BRCT, FF, WW, and FHA
domains [49]. Tyrosine phosphorylated peptides can be recognized by SH2 or PTB domains
[158]. The SH2 domain family represents the largest class of tyrosine phosphopeptide recognition
modules and is found in 111 different human proteins [159]. In addition to the phosphorylated
tyrosine residue (pTyr) itself, these domains also recognize peptide residues adjacent to the
phosphorylation site. For example, the SH2-domains of the SHP protein preferentially bind to
a pTyr-X-X-Leu sequence stretch, i.e., they recognize a leucine (Leu), which is three amino
acids apart from the phosphorylation site (“X” denotes a variable amino acid). In contrast, CRK
SH2-domains recognize a pTyr-X-X-Pro sequence, which contains a proline (Pro) instead of
leucine at the respective sequence position [160]. This recognition of additional residues in the
peptide ensures a high specificity at the receiver side and underscores that the peptide moiety
of the signaling particle is more than a mere carrier, but instead plays an important role for the
construction of specific transmitter-receiver pairs.
C. More Complex Architectures for MC
By combining several kinases with receiver domains of corresponding specificity, different
communication concepts can be realized. Here, we will discuss orthogonal channels, diversity,
coding, and jamming, see Fig. 9.
P1 (Orthogonal channels): Orthogonal channels can be realized by using two kinases, which
differ in the type of their activation mechanism and the specificity of their phosphorylation
(Fig. 9a). For example, transmitter 1 (T1) could be a light-activated kinase and T2 a pH-activated
kinase, each combined with a specific receiver domain (R1 or R2). In this system, changes in
irradiation and pH can then be detected in the same setup based on the signals S1 and S2. This
setup allows the interference free multiplexing of signals.
P2 (Diversity): By selecting suitable signal peptides and receiver domains, two signals cannot
only be observed separately, but can also be processed jointly to produce a combined output
signal. One setup for such a processing is shown in Fig. 9b. Here, it is sufficient if one of
the two stimuli is present to trigger the signal at the receiver. The difference to the situation
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Fig. 9. More complex architectures for MC based on phosphopeptides. (a) Simultaneous orthogonal transmission of two different
signals (S1, S2). MCSs realizing (b) diversity, (c) coding, and (d) jamming. Transmitters (T) and receivers (R) of different types
are labelled with small subscript numbers. x and y denote two distinct phosphorylation sites either in two different peptides (a,
b) or within the same peptide (c, d).
shown in Fig. 9a is that instead of two specific recognition domains, a receiver domain (R3) with
low specificity is now used which can bind the phosphorylation sites x and y of both peptides.
This can be interpreted as a form of diversity. For example, let’s assume that both peptides
convey the same information (e.g. both convey information bit “1”). If we further assume that
diffusion is the main transportation mechanism to bring the phosphorylation sites of the peptides
into contact with the recognition domain at the receiver, then, due to the random nature of the
diffusion process, one of the peptides may not arrive at the receiver. Alternatively, one of the
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peptides may not be phosphorylated at all, because the respective kinase was not activated by a
stimulus. However, for the considered setup, it is sufficient if one of the peptides carrying one
of the phosphorylation sites arrives at the receiver, which implies a diversity gain.
P3 (Coding): For the architecture shown in Fig. 9c, both stimuli (e.g. light and pH change) must
be present so that a signal can be detected at the receiver. The carrier molecule used is a peptide
that has two distinct phosphorylation sites for kinases T1 and T2. This requires a receiver with
two recognition sites for phosphoryl groups, each of which on its own binds the phosphoryl
groups too weakly to trigger the signal. The simultaneous binding of two phosphoryl groups
results in a significantly stronger binding, which triggers a detectable signal at the receiver. This
may be seen as a form of repetition coding as a signal is generated only if both phosphoryl
groups are observed at the receiver. This principle is used in nature, for example, by the ZAP70
adapter protein, which has two SH2 domains. The simultaneous binding of both SH2-domains
causes a >100-fold increase in affinity compared to the interaction of a single SH2 domain
[161].
P4 (Jamming): For the architecture shown in Fig. 9d, the transmitter and the signal peptides
are similar to those for the coding scheme shown in Fig. 9c. However, the receiver (R4) has
different properties compared to R3. If a second phosphorylation is added at position y, this
leads to a weakening of the binding due to unfavourable interactions with the receiver, such that
no signal is detected. In a communication context, this may be interpreted as a jamming of the
signal. In particular, if the intended message is encoded via phosphorylation site x, adding the
second phosphorylation y jams the received signal. An example of such a receiver in nature is a
14-3-3 protein that specifically recognizes a Cdc25B signal protein phosphorylated at the serine
323 position. If a second phosphorylation is added at the adjacent serine 321, the interaction
with the receiver is disrupted [162].
The principles for switchable interactions described in Fig. 9 are widely used in nature.
The ELM.switches database [163] provides an overview of known switchable systems, which
might be exploited for MCS design. As a long-term goal, a quantitative understanding of these
signaling processes may guide the design of signaling particles that interfere with cellular
signal transduction processes in a desired fashion, e.g. by counter-balancing impaired signaling
originating from disease.
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VI. COMPARISON AND PRACTICAL CONSIDERATIONS
In Sections II-V, we have described three different classes of candidate signaling particles for
synthetic MCSs. Each of these classes has certain advantages and disadvantages for implementa-
tion. For example, ions exhibit a high particle stability and speed of diffusion, but the uniqueness
of the signal7 is not optimal in a physiological context. NTs provide a highly unique and specific
signal, but the reversibility of their use still represents a bottleneck in the designs proposed here.
In contrast to the other classes, phosphopeptide-based communication does not require vesicles
and is highly versatile8, but the particle stability (susceptibility to proteases and phosphatases)
may constitute a limitation. The properties of the considered signaling particles are summarized
in Table III and will be discussed more in detail in the following. In particular, we will discuss
the feasibility of the implementation of the corresponding synthetic MCSs, options for mitigation
of ISI, and the speed of communication.
A. Feasibility of Technical Implementation
In order to realize the biological building blocks proposed in this article, some technical
challenges have to be met, which are addressed in the following.
• Recombinant expression of proteins: To generate sufficient amounts of the required
proteins (e.g. those shown in Fig. 3), they have to be expressed recombinantly in cells
from either prokaryotic (e.g. E. coli) or eukaryotic origin (e.g. yeast, insect or mammalian
cells). Therefore, a DNA coding for the respective protein has to be inserted, such that
the native cellular machinery of protein biosynthesis can be utilized [164]. The fact that
crystal structures for most of the proteins shown in Fig. 3 exist indicates that protocols for
the recombinant expression and subsequent purification of larger protein amounts of these
proteins are already available.
• Additional engineering: The vast majority of the proteins proposed as biological transmitter
and receiver components were directly adapted from functional biological systems and do
not require further modification, i.e., they can be readily obtained by recombinant expression
or by using them directly in the context of the native biological system.
7In a physiological environment, interference may be caused by other ions that also interact with the receiver.
8Phosphopeptides are versatile signaling particles because they can be used with large variations in the setup, i.e., different
transmitters (different kinases) and receivers (different recognition domains).
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TABLE III
PROPERTIES AND ADVANTAGES OF THE DIFFERENT CLASSES OF SIGNALING PARTICLES.
Properties Ions NTs Phosphopeptides
Transmitter control light, voltage, mechanical
stress, ligand
indirect via ion channel
(light, voltage)
light, ligand
Membrane vesicles
required
yes yes no
Regeneration possible
(Reversibility)
yes, by returning signaling
particles to the vesicles
difficult: in the presented
settings only with pipette or
axon terminal
yes, kinase is not destroyed
(ATP is regenerated in
living cells)
Energy source
(if reversible)
light by using light-driven
pumps
irreversible chemical (ATP)
Receiver output signal optical (fluorescence), ion
flow (conductivity), ligand
release from protein
ion flow (conductivity),
biological (GPCR signal)
optical (fluorescence),
surface plasmon resonance
Signal removal external addition of
chemicals: base (OH−),
chelation (EDTA)
enzymatic degradation:
acetylcholinesterase (AchE),
monoamine oxidases
(MAO)
enzymatic
dephosphorylation with
phosphatases
Underlying physiological
communication type
intercellular intercellular intracellular
System complexity moderate high moderate
Signaling particle
stability
very high high moderate
Speed (diffusion) very fast fast moderate
Uniqueness of signal moderate very good good
Versatility high moderate very high
However, protein engineering [165], [166] offers the possibility to modify protein function
in order to make them more suitable for application in MCSs. The simplest strategy is the
introduction of point mutations, i.e., the exchange of single amino acids within the protein.
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This strategy has for example been applied to engineer a light-driven calcium pump [117],
bacteriorhodopsin mutants with activity at different wavelengths [90], and GFP variants
with different pH optima [94]. This strategy may also be used to design light-driven calcium
pumps which operate at different wavelengths (prerequisite for reversibility, Table I, T5).
Such components have not yet been reported, but can presumably be constructed in a similar
manner as the already available bacteriorhodopsin variants (Fig. 4, T5) by introducing point
mutations. Besides point mutations, another strategy for protein engineering is the fusion
to unrelated protein domains of synergistic function9, which can be considered as part of a
modular toolbox [166]. For instance, a fusion construct of GFP (Fig. 3c) and the calcium-
binding protein calmodulin has lead to the development of the calcium sensor GCaMP which
shows a pronounced fluorescence only upon the presence of calcium ions [121]. Moreover,
light-inducible protein kinases have been developed using a similar approach [154]–[156].
Another interesting application would be a fusion to domains that allow for a fixation at
certain carrier materials (e.g. magnetic nanoparticles) [167]–[169] to facilitate the design
of MCSs with a defined geometry.
Additional engineering will also be required to implement some of the more complex
systems proposed in this survey. For example, membrane proteins have to be forced into
the correct orientation when they are inserted into vesicles (see below).
• Membrane protein reconstitution: Some of the systems we propose require the reconstitu-
tion of membrane proteins into vesicles, which is a challenging task. However, the artificial
construction of such proteoliposomes has been widely reported [81]–[85], [170], and due
to the fast progress in the field of synthetic biology, there is a continuous development
of corresponding new methods [170]. As vesicles containing only physiological types of
lipids are sometimes not sufficiently stable, so-called polymersomes which have membranes
consisting of non-lipid polymers, or hybrid vesicles containing both polymers and lipids
may be used as an alternative [81].
Remark 4: Instead of employing artificial vesicles, most of the presented building blocks could
be realized using entire cells in which the respective membrane proteins are recombinantly ex-
pressed. While this may be easier from a technical point of view and facilitate the implementation
of reversibility, it would also require higher concentrations of signaling particles due to the much
9Cooperative function of two or more agents which allows for faster achievement of a common goal.
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bigger size of the transmitter/receiver systems. Moreover, it would most certainly lead to a high
level of noise because of the high complexity and the plethora of natural transmembrane proteins
and signaling cascades present in cells which could interfere with the desired signaling processes.
Finally, in the context of applications within the human body (e.g. targeted drug delivery), the
usage of entire cells may be problematic because of the high amount of surface proteins which
could trigger an immune reaction.
B. ISI Mitigation via Signal Removal
MCSs are impaired by ISI which is caused by the dispersive nature of the diffusion process. In
particular, when the transmitter emits consecutive symbols, the signaling particles of previously
transmitted symbols may be observed at the receiver in the current symbol interval. Since ISI
is a common problem also in conventional wireline and wireless communication systems, many
approaches for ISI mitigation exist [171]. In conventional communication systems, equalization
at the receiver is employed to combat ISI. Although, equalization has also been proposed as an
option for MCSs [172], it may be challenging to implement even simple schemes, such as linear
equalization, at nano-scale. Alternatively, in natural MCSs, ISI is usually mitigated by removing
the signaling particles from the channel. This biological approach also seems to be a viable
option for ISI mitigation in synthetic MCSs. In the following, we will discuss mechanisms for
particle removal for each of the considered signaling particles.
• Protons: If protons are used as signaling particles, then adding a basic solution capable of
reversing the pH change caused by the transmitter system is the simplest option for removal
of the signaling particles. Like the acidic solution (Fig. 4, T1), this basic solution can be
released into the channel e.g. by an electrically controlled pipette after symbol detection.
In a physiological environment, where such a pipette is not available, raising the pH value
can be achieved for example by decarboxylation reactions of amino acids or urea, which
consume protons [173]. In the presence of the enzyme urease, urea is cleaved into CO2 and
NH3. The latter acts as a base and can thus lead to a neutralization of the acidic liquid in
the channel. This cleavage of urea occurs also in nature, e.g. as a mechanism to remove
acidic carbohydrate fermentation products in human saliva [174]. Moreover, pathogenic
Helicobacter pylori, which evokes gastritis and gastric cancer in humans, uses urease to
buffer the highly acidic gastric liquid [175].
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• Calcium ions: Calcium ions can be chemically shielded with a chelating agent such as
ethylenediaminetetraacetate (EDTA) [176] or ethylene glycol-bis(β-aminoethyl ether)-N,N,N’
,N’-tetraacetic acid (EGTA). In particular, these substances can bind to calcium ions and
prevent them from further interaction with their environment. By releasing an EDTA/EGTA
solution into the channel as soon as a signal has been detected, the calcium ions released in
the current symbol interval are neutralized and cannot cause interference in future symbol
intervals. Hence, ISI is mitigated.
• NTs: For NTs, in nature, signal removal is either achieved by symporters, which pump the
NT into separated compartments [131], or by enzymes, which degrade the NT [47]. The lat-
ter principle has the advantage that it can be easier to implement in synthetic MCSs as fewer
biological building blocks are needed. A theoretical study of NT removal via enzyme has
been provided for acetylcholine in [177], which can analogically to a physiological process
at neuromuscular junctions be eliminated by the enzyme acetylcholinesterase (Fig. 3i). In
an analogous manner, dopamine and serotonin can be degraded by monoamine oxidase-A.
• Phosphopeptides: For modified peptides as signaling particles, the phosphorylation can
be removed by phosphatases to avoid interference with subsequent signals. One option for
regulating such phosphatases are light-controlled inhibitors, which are reversibly activated by
irradiation with UV light [178]. Alternatively, phosphatases with pH-dependent activity were
developed [179]. A modular protein assembly approach was used to design a prototype that
can detect tyrosine phosphorylation and immediately activate phosphatase without requiring
further external stimuli [180].
C. Speed of Communication
The time scales at which the different processes needed for signal transmission occur at
transmitter and receiver as well as in the channel are crucial for MCS design as they ultimately
limit the achievable data rate. The quantity, which is the most straightforward to measure, is the
speed of diffusion (Fig. 2). However, in order to estimate the speed of the entire communication
process, the speed of the proteins involved as well as the time for building up concentration
gradients sufficient for detection need to be taken into account as well. A comprehensive review
of these processes is beyond the scope of this article. We will therefore only give a broad
overview of the respective time scales; a comprehensive overview of time ranges of biological
processes with many useful model calculations is given in [181] and the corresponding database
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[37]. One approach that may be exploited to speed up synthetic MCSs is flow. In particular, flow
is also used in nature as a biological processes that facilitates the transportation of chemical
species across the human body.
• Transport in channel: Individual molecular events, such as an ion flowing through an ion
channel or an enzyme catalyzing a reaction, are typically very fast. For example, one bacte-
riorhodopsin molecule can pump about 188 protons per second [37]. However, depending
on the density of bacteriorhodopsin in the vesicle, the proton gradient needed to activate the
receiver, and the distance between transmitter and receiver, it may take considerably longer
to achieve a desired macroscopic effect. Some model calculations for such macroscopic
processes for bacteriorhodopsin have been performed in [89]. In an experimental study,
E. coli cells were transfected with blue-absorbing and green-absorbing proteorhodopsins,
which are two different types of proton pumps closely related to bacteriorhodopsin. A
change of 5 − 30 nM in proton concentration of the cell suspension was achieved after
about 60 s with an approximately linear evolution over time [182].
• Ion channels: For ion channels, a good estimate for the number of ions that can be
transported through a single channel is on average about 107 per second [37] with a range
from about 103 s−1 to 108 s−1. Some exemplary permeability rates (number of ions that flow
through the channel in a certain time span) are summarized in Table IV. This compilation
includes a subset of the channels suggested in this article for which such information was
available in the literature. Although the channels are rather fast on the level of a single
molecule, the time needed to detect an effect at the cellular level (for example in Xenopus
oocytes) is in the range of a few seconds [183]. However, if artificial vesicles with ion
channels are created, the required time span will be highly dependent on the density of the
ion channels in the membrane.
• Transporters: Transporters are in most cases much slower than ion channels with a typical
transport rate of ≈ 100 molecules s−1 [181]. Nevertheless, if a cell has e.g. 10,000 trans-
porters of a certain type in its membrane, 106 molecules can be transported in total per
second. For glucose transporters in certain cell types, it has been estimated that they make
up about 2 % of the total membrane surface [181]. How many molecules can be exported
per time unit will critically depend on how easily the corresponding membrane protein can
be inserted into a vesicle membrane and what density can be achieved.
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TABLE IV
PERMEABILITY RATES FOR SELECTED ION CHANNELS. CHANNEL 1 IS AN EXAMPLE FOR A VOLTAGE-GATED PROTON
CHANNEL (PROTONS, T3), CHANNEL 2 IS A VOLTAGE-GATED CALCIUM CHANNEL (CALCIUM IONS, T3). CHANNEL 3 CAN
BE USED AS A RECEIVER FOR ACETYLCHOLINE (NTS, R1). CHANNELS 4, 5, 6, AND 7 ARE ADDITIONAL EXAMPLES
DEMONSTRATING THE TYPICAL RANGE OF ION TRANSPORT RATES.
Ion channel Permeability rate [s−1] References
1 Voltage-gated proton channel Hv1 6.0 · 10
3 [184], [185]
2 Voltage-gated calcium channels (e.g. Cav1.1) ≈ 10
6 [44]
3 Nicotinic acetylcholine receptor 2.5 · 107 [186]
4 Potassium channel KcsA ≈ 108 [187]
5 Voltage-gated sodium channel Nav1.4 ≈ 10
7 [188]
6 Cation channel gramicidin 1.5 · 107 [189]
7 Calcium channel CRAC 1.1 · 104 [190]
• Receptors: For GPCRs, ligand binding happens on a microsecond time scale [191] and
the conformational rearrangements required for receptor activation take place on a micro-
to millisecond range [192]. However, current FRET experiments to readout the receptor
activation at the cellular level would then take multiple tens of seconds or even minutes
[193].
• Enzymatic reactions: For some of our proposed building blocks, such as the degradation
of NTs and the addition and removal of peptide modifications, enzymes are required. The
speed at which an enzyme catalyzes its reaction is dependent on the concentration of the
enzyme itself and the substrate (target molecule) the enzyme binds to. The general form of
an enzymatic reaction is as follows:
E + S
k1
k
−1
ES
kcat
E + P, (1)
where enzyme E forms with its substrate S an enzyme-substrate complex ES with a certain
rate constant k1. This complex can either dissociate, with the reaction rate constant k−1,
and form E and S, or react, with the reaction rate constant kcat, and form an E molecule and
a product molecule P [194]. Note that the enzyme itself is not consumed in this process.
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TABLE V
KINETIC CONSTANTS FOR SELECTED ENZYME-SUBSTRATE COMBINATIONS. ENZYMES 1 AND 2 CAN BE USED FOR NT
DEGRADATION, ENZYME 3 IS AN EXEMPLARY ENZYME FOR PROTEIN PHOSPHORYLATION AND ENZYME 4 FOR PROTEIN
DEPHOSPHORYLATION (THEIR INDICATED KINETIC VALUES WERE DETERMINED FOR A SAMPLE PEPTIDE.). ENZYMES 5, 6,
AND 7 ARE ADDITIONAL EXAMPLES DEMONSTRATING THE ACTIVITY RANGE OF DIFFERENT ENZYMES.
Enzyme Substrate kcat [s
−1] KM [mM] References
1 Acetylcholinesterase acetylcholine 3.0 · 104 0.1 [195], [196]
2
Monoamine oxidase-A
(MAO-A)
dopamine 1.83 0.23
[197]
serotonin 1.80 0.40
3 Protein kinase N1 peptide 0.7 0.013 [198]
4 Protein phosphatase
2Cα
peptide 0.3 0.09 [199]
5 Catalase H2O2 4.0 · 10
7 1.6 [196], [200]
6 Triosephosphate
isomerase
glycerinaldehyde
3-phosphate
4.2 · 103 0.5 [196], [201]
7 Chymotrypsin N-Acetyl-Val-OMe 1.7 · 10−1 88 [196], [202]
The speed v of this reaction may be approximated (apart from additional factors such as
cooperative binding that can affect v) by use of the Michaelis-Menten equations [194] as
follows
v = kcat · [E]t ·
[S]
KM + [S]
= vmax ·
[S]
KM + [S]
, (2)
where square brackets denote the concentrations of the respective molecules, [E]t is the total
concentration of the enzyme (free+substrate-bound), vmax is the maximum reaction speed
at the given enzyme concentration, and KM is the Michaelis constant. Thus, knowing kcat,
KM , and the concentrations of enzyme and substrate, the speed of the reaction can be
calculated. In particular, in (2), kcat stands, in simple terms, for the number of reactions an
enzyme makes per unit time and KM for the substrate concentration at which 50 % of the
maximum reaction speed is reached [181].
Remark 5: Typical values of kcat vary between 10
−2 s−1 and 107 s−1 with the median
approximately at 14 s−1. Moreover, the range of the values ofKM varies approximately from
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10−5 mM up to 103 mM with a median value of 0.130 mM [181], [203]. Please note that
these values are not only enzyme-specific, but they also depend on the respective substrate
and environmental conditions such as pH or ionic strength. For illustration, we provide
concrete values of kcat and KM for some selected exemplary enzyme-substrate combinations
in Table V. Specific values for many more enzymes and substrates are available in the
BioNumbers data bank [37].
VII. CONCLUSION
In this paper, we provided a comprehensive survey of the biological components that can serve
as building blocks for the transmitter and the receiver and as signaling particles for synthetic
MCSs. Adopting a signaling particle centric presentation, we argue that cations, NTs, and
phosphopeptides represent promising candidate signaling particles. They can be used to interact
with natural physiological processes and as information carriers in synthetic MCS employing
engineered protein systems as transmitters and receivers. The engineered transmitter/receiver
systems considered in this survey mainly rely on physiological protein components of well-
characterized functionality. However, the engineering of functional transmitter/receiver systems
based on these isolated components still remains a challenging task, particularly when insertion
of proteins into vesicle membranes with defined inside-outside geometry is required. For each of
the presented synthetic MCSs architectures, the ensuing advantages and limitations are outlined
and references to the relevant literature in synthetic biology are provided. This survey will help
both theoreticians and experimentalists to develop a better understanding of the options available
for the design and implementation of biological synthetic MCSs and interfaces for natural MCS.
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APPENDIX A
GLOSSARY OF BIOLOGICAL CONCEPTS AND TERMS
For convenience, in the following table, we explain the most important biological concepts
and terms appearing in this article.
TABLE VI
EXPLANATION OF RELEVANT BIOLOGICAL AND CHEMICAL TERMS. FOR MORE DETAILED DESCRIPTIONS, WE RECOMMEND
REFERENCES [204]–[206].
Term Description
From amino acids to proteins
Amino acid Organic compound containing an amine (NH2) group, a carboxyl (COOH) group, and
a specific side chain. Building block of a protein.
Peptide Short chain of amino acids (smaller than a protein) linked by peptide bonds.
Protein Large biomolecule, consisting of one or more long chains of amino acids.
Crystal structure Three-dimensional model of the structure of a molecule (e.g. a protein) resolved by
X-ray crystallography.
Residue Single amino acid within a peptide or protein.
Proteome Entire set of proteins expressed by a certain organism, tissue or cell.
Protein folding and modifications
Chaperone Protein that assists the folding process of other proteins or the assembly of
macromolecular structures.
Molecular maturation Collective term for additional modifications taking place after protein biosynthesis,
such as cleavage, posttranslational modifications and oligomerization. . . .
Posttranslational
modification of
proteins/peptides
Covalent modification of a protein or a peptide after protein biosynthesis.
Methylation/Acetylation/
Ubiquitination
Examples for posttranslational modifications: addition of a methyl (CH3) / acetyl
(CH3CO) / ubiquitin (a small regulatory protein) group.
Different oligomerization states
Monomer Single molecule which can undergo oligomerization and thereby contribute a
constitutional unit to a macromolecule.
Dimer Chemical structure formed from two subunits.
Oligomer Macromolecule formed from a few subunits.
Homo-/Hetero- Consisting of identical/different sub-molecules.
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Protein domains
Protein domain Part of a protein which can evolve, fold, and function independently from the rest of
the protein chain.
Adapter domain Domain mediating specific interactions with a binding partner.
Homologous domain Domain which is similar to another one due to a common evolutionary origin.
Enzymes – Biological catalysts
Kinase Transfers a phosphate group from ATP to a protein.
ATPase Catalyzes cleavage of ATP to ADP and a phosphate group, uses released energy to
drive a chemical reaction that would not occur otherwise.
Protease Cleaves a protein by hydrolysis of peptide bonds.
Phosphatase Removes a phosphate group from a phosphorylated protein.
Allosteric regulation Regulation of an enzyme by binding an effector molecule at a site other than the
enzyme’s active site.
Overview of chemical terms
Moiety Chemical group (e.g. methyl moiety, acetyl moiety, peptide moiety)
Acidic conditions Environmental conditions characterized by a low pH value, i.e., a high proton
concentration.
Protonation Covalent addition of a proton to a molecule, formation of the conjugate acid.
Hydrolysis Cleavage of a biomolecule accompanied by the consumption of a water molecule.
Chelating agent Chemical agent that binds certain metal ions by forming two or more coordinate
bonds. May be used to remove or chemically shield the metal ions.
Miscellaneous
Surface-plasmon resonance Biophysical method to detect biomolecular interactions.
Recombinant DNA/protein DNA/protein sequence engineered by laboratory methods of genetic recombination
such as molecular cloning.
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